Emerson Electric Co.
EMRIndustrialsNASDAQSpecialty Industrial Machinery
Scan Results
Daily timeframePart of the industrials sector, Emerson Electric Co. (EMR) is listed under Specialty Industrial Machinery. At a $84.87B market cap, Emerson Electric Co. ranks as a large-cap company within industrials. It operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments.
Market Cap
$84.87B
Beta
1.23
P/E (TTM)
33.29
P/E (Fwd)
21.00
EPS (TTM)
$4.57
EPS (Fwd)
$7.24
ROE
12.8%
ROA
6.9%
Cash
$2.18B
Total Debt
$13.80B
Free CF
$3.71B
52W Change
15.7%
Annual Financials
Cash vs Debt
Where EMR stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, EMR finished 3.97% above its 150-day moving average ($143.29) and 5.28% above its 200-day moving average ($141.51). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is EMR overbought or oversold?
At the September 3, 2026 close, EMR's RSI(14) was 25.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $2.18B in cash, though total debt stands at $13.80B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $3.71B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 12.8% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.9% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $13.80B (2022) to $18.02B (2025), reflecting a 31% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing EMR.